Prognostic factors predicting recurrence in borderline ovarian tumors.

[1]  R. Rouzier,et al.  Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors. , 2008, American journal of obstetrics and gynecology.

[2]  Judy L. Smith,et al.  Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. , 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  Jie-lin Ren,et al.  A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors. , 2008, Gynecologic oncology.

[4]  W. Gotlieb,et al.  Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors. , 2007, Fertility and sterility.

[5]  P. Neven,et al.  Management of borderline ovarian neoplasms. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Staff,et al.  Surgery of borderline tumors of the ovary: retrospective comparison of short‐term outcome after laparoscopy or laparotomy , 2007, Acta obstetricia et gynecologica Scandinavica.

[7]  A. Malpica,et al.  The Recurrence and the Overall Survival Rates of Ovarian Serous Borderline Neoplasms With Noninvasive Implants is Time Dependent , 2006, The American journal of surgical pathology.

[8]  I. Busmanis,et al.  Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004 , 2006, International Journal of Gynecologic Cancer.

[9]  A. Gadducci,et al.  Management of borderline ovarian tumors: results of an Italian multicenter study. , 2006, Gynecologic oncology.

[10]  G. Chatellier,et al.  Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. , 2005, Gynecologic oncology.

[11]  J. McKenney,et al.  Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors): Outcome-Based Study of 276 Patients With Long-Term (≥5-Year) Follow-Up , 2005, The American journal of surgical pathology.

[12]  E. Daraï,et al.  Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  F. Landoni,et al.  Are borderline tumors of the ovary safely treated by laparoscopy? , 2004, Gynecologic oncology.

[14]  G. Ganem,et al.  Recommandations pour la pratique clinique Standards, Options et Recommandations 2003 pour le traitement médical de première ligne des patientes atteintes de tumeurs épithéliales malignes de l'ovaire, mise à jour (rapport abrégé) , 2004 .

[15]  P. Hartge,et al.  Survival among women with borderline ovarian tumors and ovarian carcinoma , 2004, Cancer.

[16]  C. Haie-meder,et al.  Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  R. Winn,et al.  The NCCN clinical practice guidelines in oncology: a primer for users. , 2003, Journal of the National Comprehensive Cancer Network : JNCCN.

[18]  E. Trimble,et al.  Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. , 2002, Gynecologic oncology.

[19]  D. Mutch,et al.  Epithelial Ovarian Tumors of Low Malignant Potential: The Role of Microinvasion , 2002, Obstetrics and gynecology.

[20]  H. Ngan,et al.  FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. , 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[21]  R. Scully.  Histological Typing of Ovarian Tumours , 1999, World Health Organization. International Histological Classification of Tumours.

[22]  D. Gershenson,et al.  Serous borderline tumors of the ovary with noninvasive peritoneal implants , 1998, Cancer.

[23]  L. Levy,et al.  Ovarian serous borderline tumors with invasive peritoneal implants , 1998, Cancer.

[24]  S. Hsueh,et al.  The role of DNA flow cytometry in borderline malignant ovarian tumors , 1996, Cancer.

[25]  E. Yordan,et al.  Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  P. Rose,et al.  Accuracy of frozen-section (intraoperative consultation) diagnosis of ovarian tumors. , 1994, American journal of obstetrics and gynecology.

[27]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[28]  M. Weinstock,et al.  Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. , 1989, Cancer.

[29]  P Maisonneuve,et al.  Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[30]  C. Tournigand,et al.  [Clinical practice guidelines: Standards, Options and Recommendations for first line medical treatment of patients with ovarian neoplasms (summary report)]. , 2004, Bulletin du cancer.

[31]  S. Robboy,et al.  Pathology of the Female Reproductive Tract , 2002 .

[32]  R. Osborn.  Histological Typing of Ovarian Tumours. International Histology Classification of Tumours, S.F. Serov, R.E. Scully. World Health Organization, Geneva (1973), 56, Slides: £21.00, US$51.00, Book only: £6.65, US$16.50 , 1975 .

[33]  C A SALVATORE,et al.  [Carcinoma of the ovary]. , 1960, Anais brasileiros de ginecologia.